Xconomy’s Digital Events →
Waltham, MA-based Synchroneuron is developing a drug for tardive dyskinesia.
Sponsored · Whitepaper
How incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.
Sponsored · Webinar
Phenotypic Screening & Profiling to Understand a Compound's Disease Impact
Knowing the volume of procedures and growth trends by site of care can allow you to understand the market demand for your product
© 2007-2021, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.